228 related articles for article (PubMed ID: 19174507)
1. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model.
Wu ZP; Gao CW; Wu YG; Zhu QS; Yan Chen ; Xin Liu ; Chuen Liu
Integr Cancer Ther; 2009 Mar; 8(1):88-92. PubMed ID: 19174507
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
3. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
4. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.
Valable S; Lemasson B; Farion R; Beaumont M; Segebarth C; Remy C; Barbier EL
NMR Biomed; 2008 Nov; 21(10):1043-56. PubMed ID: 18615861
[TBL] [Abstract][Full Text] [Related]
5. The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway.
Liu D; Cao G; Cen Y; Liu T; Peng W; Sun J; Li X; Zhou H
Int Immunopharmacol; 2013 Oct; 17(2):237-44. PubMed ID: 23791618
[TBL] [Abstract][Full Text] [Related]
6. [Hydrogen sulfide stimulates the development of rat glioblastoma].
Li ZY; Liu SC; Xu PJ; Yang Z; Zhang T
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):254-8. PubMed ID: 22781035
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
8. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model.
Doblas S; Saunders D; Kshirsagar P; Pye Q; Oblander J; Gordon B; Kosanke S; Floyd RA; Towner RA
Free Radic Biol Med; 2008 Jan; 44(1):63-72. PubMed ID: 18045548
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis induced by rat glioma cells in vitro].
Niida H; Minakawa T; Tanaka R
No Shinkei Geka; 1992 Nov; 20(11):1169-72. PubMed ID: 1280347
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
11. Effects of all‑trans retinoic acid on VEGF and HIF‑1α expression in glioma cells under normoxia and hypoxia and its anti‑angiogenic effect in an intracerebral glioma model.
Liang C; Guo S; Yang L
Mol Med Rep; 2014 Nov; 10(5):2713-9. PubMed ID: 25201493
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effect of 125IUdR on the glioma cell line C6 in vitro and in vivo].
Wu B; You C; Liu XD; Cai BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):671-4. PubMed ID: 15460416
[TBL] [Abstract][Full Text] [Related]
14. Application of the disc angiogenesis system to tumor-induced neovascularization.
Nelson MJ; Conley FK; Fajardo LF
Exp Mol Pathol; 1993 Apr; 58(2):105-13. PubMed ID: 7684337
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in malignant glioma--a target for antitumor therapy?
Tuettenberg J; Friedel C; Vajkoczy P
Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
[TBL] [Abstract][Full Text] [Related]
16. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
[TBL] [Abstract][Full Text] [Related]
18. Quantification and distribution of neovascularization following microinjection of C6 glioma cells in rat brain.
Péoc'h M; Le Duc G; Trayaud A; Farion R; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 1999; 19(4B):3025-30. PubMed ID: 10652587
[TBL] [Abstract][Full Text] [Related]
19. AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma.
Rivera E; Arrieta O; Guevara P; Duarte-Rojo A; Sotelo J
Br J Cancer; 2001 Nov; 85(9):1396-9. PubMed ID: 11720480
[TBL] [Abstract][Full Text] [Related]
20. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
